Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: ROCHE DIAGNOSTICS CORPORATION
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2023-10-01 to 2024-09-30
Current total value of award: $415088.71
Description: CANCER ANTIBODIES REAGENTS